DNA & Genetics Lonza’s Synaffix Collaborates with Qurient Therapeutics on Dual-Payload ADC DevelopmentBy adminSeptember 26, 20250 Synaffix, a Lonza company focused on commercializing its clinical-stage platform technology for the development of antibody-drug conjugates (ADCs), entered into…
DNA & Genetics NIH Funding Cuts’ Impact on Drug Discovery and DevelopmentBy adminSeptember 26, 20250 Changes in the political climate of the United States are spilling into scientific research. While many past administrations, of both…
Probiotics Novo Nordisk And Novonesis Team Up For Dietary Supplements DevelopmentBy adminSeptember 9, 20250 The Danish firms plan to develop and test synbiotic dietary supplements – combining probiotics and prebiotics – that can have…
Microbiome Microbiome’s Hidden Role in Early Tumor DevelopmentBy adminSeptember 7, 20250 In recent years, the intricate relationship between the human microbiome and cancer development has emerged as a focal point of…
